Reem Hal/LinkedIn
Dec 25, 2025, 23:39
Reem Hal Shares New Clinical Capsule: Thrombosis in Cancer Patients
Reem Hal, Senior Pediatric Oncology Clinical Pharmacist at Borg El Arab Main University Hospital, shared a post on LinkedIn:
“Clinical Capsule | Oncology Rounds
Capsule #5 – Thrombosis in Cancer Patients
‘The cancer didn’t cause the ICU admission — the missed prophylaxis did.’
A patient with multiple myeloma on
lenalidomide + dexamethasone
missed thromboprophylaxis →
acute myocardial infarction. ICU admission.
Clinical Pearl
IMiD-based regimens dramatically increase thrombotic risk.
Standard practice
- Low risk → Aspirin
- High risk → LMWH or DOAC
Missed prophylaxis may lead to
- MI or stroke
- Treatment interruption
Take-home message
In multiple myeloma, thromboprophylaxis is not optional — it is life-saving.”
Follow the latest in Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia